The Healthcare Industry Summit and the official opening of AstraZeneca's northern China headquarters was held in Beijing Economic-Technological Development Area (BDA) on Friday. 

The launch of its northern China headquarters marks the first step of the company's China regional headquarters strategy this year. The new headquarters, located in the Beijing Economic-Technological Development Area (BDA), will oversee the company's operation, management and marketing in northern China and northeastern China, including Beijing and Tianjin.

The headquarters will focus on industries related to smart medicine and technology, as well as the use of innovative technologies in the biomedicine and healthcare industries. With the full operation of the company's northern China headquarters, the Community Intelligence Healthcare Innovation Center, the Beijing International Life Science Innovation Campus and the AstraZeneca Global R&D China Beijing Office will also be established in the BDA.

The company also held a forum about hospital management to provide in-depth interpretation and discussion of policies and key issues related to promoting the high-quality development of public hospitals. Another forum about medical innovation, medical organizations and smart primary care partnership was also sponsored.